NeuroD1 Antibody (C-term) Blocking Peptide

NeuroD1 Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP2021b
Catalog Number: AC-BP2021b
Size: 500 µg
Datasheet
Request Information
Background:
NeuroD1 is a transcriptional activator that acts as a differentiation factor during neurogenesis. It has been demonstrated to bind to the insulin gene E-box. Efficient DNA binding requires dimerization with another basic helix-loop-helix (bHLH) protein. Defects in NEUROD1 are a cause of maturity onset diabetes of the young type VI (MODY6). MODY6 is a form of non-insulin-dependent diabetes mellitus characterized by an autosomal dominant mode of inheritance, onset during young adulthood and a primary defect in insulin secretion.

Other Names:
Neurogenic differentiation factor 1, NeuroD, NeuroD1, Class A basic helix-loop-helix protein 3, bHLHa3, NEUROD1, BHLHA3, NEUROD

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2021b was selected from the C-term region of human NeuroD1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: NEUROD1

Gene ID: 4760
Primary Accession: Q13562
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:NeuroD1 Antibody (C-term) Blocking Peptide